Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03104413 |
|---|---|
| Brief Title: | A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment |
| First Submitted : | April 4, 2017 |
| First Submitted that Met QC Criteria : | April 4, 2017 |
| First Posted : | April 7, 2017 |
| Results First Submitted : | March 31, 2022 |
| Results First Posted with QC Comments : | April 28, 2022 |
| Results First Submitted that Met QC Criteria : | May 19, 2022 |
| Results First Posted : | June 14, 2022 |
| Certification/Extension First Submitted : | July 16, 2021 |
| Certification/Extension First Submitted that Met QC Criteria : | May 19, 2022 |
| Certification/Extension First Posted : | June 14, 2022 |
| Last Update Submitted that Met QC Criteria : | May 19, 2022 |
| Last Update Posted : | June 14, 2022 |